Search - tctmd.com

Displaying 181 - 200 of 591

Sort: Relevancy | Date

News Daily News

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

Caitlin E. Cox

October 08, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2020

Caitlin E. Cox

August 28, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2020

Shelley Wood

July 31, 2020

News Daily News

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Michael O'Riordan

July 07, 2020

News Daily News

PCI or Not, Post-ACS Bleeding Is Tied to Mortality

Todd Neale

July 06, 2020

News Daily News

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

Yael L. Maxwell

June 30, 2020

News Industry News

CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial

June 01, 2020

News Daily News

FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention

Shelley Wood

June 01, 2020

News Daily News

Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published

Michael O'Riordan

April 27, 2020

News Conference News ACC 2020

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

Todd Neale

March 31, 2020

Presentation ACC 2020

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Presenter: Yangsoo Jang

March 30, 2020

News Conference News ACC 2020

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Yael L. Maxwell

March 30, 2020

News Opinion Conversations in Cardiology

Conversations in Cardiology: Uncovered Struts on OCT After 12 Years?

March 27, 2020

News Daily News

More Support for DOAC-Based Double Therapy After PCI for A-fib Patients

Todd Neale

March 16, 2020

News Daily News

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

Yael L. Maxwell

March 10, 2020

News Daily News

New ABCD-GENE Score Taps Clinical, Genetic Factors to ID Clopidogrel Nonresponders

Yael L. Maxwell

March 06, 2020

News Daily News

Validated ARC-HBR Criteria Highlight ‘Eye-opening’ Proportion of PCI Patients at Risk

Yael L. Maxwell

March 03, 2020

Advertisement

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

TCTMD’s Top 10 Most Popular Stories for August 2020

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

TCTMD’s Top 10 Most Popular Stories for July 2020

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

PCI or Not, Post-ACS Bleeding Is Tied to Mortality

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial

FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention

Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Conversations in Cardiology: Uncovered Struts on OCT After 12 Years?

More Support for DOAC-Based Double Therapy After PCI for A-fib Patients

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

New ABCD-GENE Score Taps Clinical, Genetic Factors to ID Clopidogrel Nonresponders

Validated ARC-HBR Criteria Highlight ‘Eye-opening’ Proportion of PCI Patients at Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content